What is the price target for LINE stock?
25 analysts have analysed LINE and the average price target is 42.61 USD. This implies a price increase of 29.41% is expected in the next year compared to the current price of 32.93.
NASDAQ:LINE • US53566V1061
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LINEAGE INC (LINE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-03-20 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-03-18 | Compass Point | Initiate | Buy |
| 2026-03-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-03-04 | Truist Securities | Maintains | Buy -> Buy |
| 2026-03-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-03-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-02 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-27 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-02-26 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-01-13 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2026-01-09 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-01-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-18 | Baird | Downgrade | Outperform -> Neutral |
| 2025-12-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-11-14 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-11-12 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-11-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-06 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-11-06 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-10-22 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.342B 8.38% | 5.34B -0.03% | 5.355B 0.28% | 5.575B 4.11% | 5.765B 3.41% | 4.683B -18.77% | 6.75B 44.14% | 7.626B 12.98% | |
| EBITDA YoY % growth | 1.25B 18.34% | 1.223B -2.15% | 1.147B -6.21% | 1.232B 7.41% | 1.299B 5.44% | 1.414B 8.85% | 1.412B -0.14% | N/A | |
| EBIT YoY % growth | 490.2M 29.34% | 347M -29.21% | 252M -27.38% | 489.77M 94.35% | 354.29M -27.66% | 458.75M 29.48% | 523.36M 14.08% | 614.96M 17.50% | |
| Operating Margin | 9.18% | 6.50% | 4.71% | 8.79% | 6.15% | 9.80% | 7.75% | 8.06% | |
| EPS YoY % growth | N/A | N/A | -0.44 84.71% | -0.74 -69.30% | -0.66 10.25% | -0.65 1.23% | -0.17 73.44% | 0.09 152.94% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.22 -164.00% | -0.16 -97.62% | -0.12 67.42% | -0.18 -298.33% | -0.20 11.36% | -0.12 22.58% | -0.50 -330.43% | -0.10 42.86% |
| Revenue Q2Q % growth | 1.352B 4.64% | 1.396B 3.41% | 1.418B 2.98% | 1.407B 5.31% | 1.435B 6.14% | 1.494B 7.02% | 1.513B 6.70% | 1.508B 7.18% |
| EBITDA Q2Q % growth | 288.07M 9.95% | 301.64M -39.55% | 316.53M -56.99% | 323.58M -66.40% | 322.76M 12.04% | 336.69M 11.62% | 341.59M 7.92% | 346.84M 7.19% |
| EBIT Q2Q % growth | 45.659M -8.68% | 57.95M -8.02% | 75.303M 7.58% | 77.923M 14.59% | 65.052M 42.47% | 80.522M 38.95% | 95.275M 26.52% | 89.508M 14.87% |
All data in USD
25 analysts have analysed LINE and the average price target is 42.61 USD. This implies a price increase of 29.41% is expected in the next year compared to the current price of 32.93.
LINEAGE INC (LINE) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of LINEAGE INC (LINE) is -0.22 USD and the consensus revenue estimate is 1.35B USD.
The expected long term growth rate for LINEAGE INC (LINE) is -5.22%.